Cardiff Oncology Inc (CRDF)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
96,466,000
EV to revenue ratio (TTM)
136.62
EV to ebitda
-3.661
Financial Performance
Revenue (TTM)
508,000
Gross profit (TTM)
-34,821,000
EBITDA
-41,915,000
Profitability
Operating margin (TTM)
-9,245.00%
Profit margin
0.00%
Return on assets (TTM)
-46.70%
Return on equity (TTM)
-94.10%
Per Share Metrics
Revenue per share (TTM)
0.01
EPS
-0.59
Diluted EPS (TTM)
-0.59
Book value
0.39
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
189.89
Price to book ratio (TTM)
3.9
Growth
Quarterly earnings growth (YoY)
-14.10%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
1
Hold
4
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.455